Correlation Between Cue Biopharma and Mind Medicine
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Mind Medicine, you can compare the effects of market volatilities on Cue Biopharma and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Mind Medicine.
Diversification Opportunities for Cue Biopharma and Mind Medicine
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cue and Mind is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Mind Medicine go up and down completely randomly.
Pair Corralation between Cue Biopharma and Mind Medicine
Considering the 90-day investment horizon Cue Biopharma is expected to generate 0.6 times more return on investment than Mind Medicine. However, Cue Biopharma is 1.68 times less risky than Mind Medicine. It trades about 0.0 of its potential returns per unit of risk. Mind Medicine is currently generating about -0.02 per unit of risk. If you would invest 134.00 in Cue Biopharma on November 29, 2024 and sell it today you would lose (3.00) from holding Cue Biopharma or give up 2.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Mind Medicine
Performance |
| Timeline |
| Cue Biopharma |
| Mind Medicine |
Cue Biopharma and Mind Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Mind Medicine
The main advantage of trading using opposite Cue Biopharma and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
| Mind Medicine vs. Cybin Inc | Mind Medicine vs. GH Research PLC | Mind Medicine vs. Awakn Life Sciences | Mind Medicine vs. ATAI Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance |